share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina

Recursion Pharmaceuticals | 4：持股变动声明-高管 Marriott Tina
美股sec公告 ·  06/28 17:19
Moomoo AI 已提取核心信息
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 6,000 shares of the company's Class A Common Stock on June 27, 2024. The transaction was executed at a price of $7.215 per share, resulting in a total market value of $43,290. Following the sale, Marriott's direct holdings in the company amount to 535,457 shares. The sale was conducted on the open market and coincided with the exercise of derivative securities, where Marriott acquired an equivalent number of shares at $1.06 each on the same day.
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 6,000 shares of the company's Class A Common Stock on June 27, 2024. The transaction was executed at a price of $7.215 per share, resulting in a total market value of $43,290. Following the sale, Marriott's direct holdings in the company amount to 535,457 shares. The sale was conducted on the open market and coincided with the exercise of derivative securities, where Marriott acquired an equivalent number of shares at $1.06 each on the same day.
Recursion Pharmaceuticals总裁兼首席运营官Tina Marriott于2024年6月27日出售了公司的6,000股A类普通股。交易价格为每股7.215美元，总市值为43,290美元。销售后，Marriott在该公司的直接持股为535,457股。该销售是在公开市场上进行的，并与衍生证券行使同时进行，Marriott在同一天以1.06美元的价格收购了相等数量的股票。
Recursion Pharmaceuticals总裁兼首席运营官Tina Marriott于2024年6月27日出售了公司的6,000股A类普通股。交易价格为每股7.215美元，总市值为43,290美元。销售后，Marriott在该公司的直接持股为535,457股。该销售是在公开市场上进行的，并与衍生证券行使同时进行，Marriott在同一天以1.06美元的价格收购了相等数量的股票。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息